# Maternal infection during pregnancy and the risk of childhood cancer: a systematic review and meta-analysis

**Authors:** Loviisa Mulanje, Lara Kim Brackmann, Alicia Lübtow, Hajo Zeeb, Wolfgang Ahrens, Manuela Marron, Rajini Nagrani

PMC · DOI: 10.1186/s12916-026-04625-1 · BMC Medicine · 2026-01-14

## TL;DR

This study finds that maternal infections during pregnancy may increase the risk of childhood cancer, with specific infections linked to specific cancer types.

## Contribution

The study provides a comprehensive meta-analysis linking specific maternal infections to childhood cancer risks, offering insights for targeted prevention.

## Key findings

- Maternal infections during pregnancy are associated with a 36% increased risk of childhood cancer overall.
- Sexually transmitted infections and viral infections are strongly linked to higher cancer risks, including leukemia.
- Genitourinary tract infections are specifically associated with increased risks of leukemia and solid tumors.

## Abstract

Maternal infections during pregnancy may increase the risk of childhood cancer (CC) in offspring by affecting foetal immunity and genetics. Existing evidence seems inconclusive, necessitating a comprehensive review to understand this association. We aimed to evaluate the risk of various CC outcomes following prenatal exposure to different types of maternal infections.

We searched Medline, Web of Science, Embase, Cochrane Library, and bibliographies for relevant studies from inception to October 2025. The study protocol was registered in PROSPERO (ID:CRD42023483706). We included original human epidemiological studies that examined the association between maternal infections during pregnancy and CC with appropriate reference groups and no language restrictions. We excluded studies if they were reviews or reports, if they did not assess individual-level infection or if they used therapies for infections (e.g., antibiotics) as markers of infection exposure. Two independent reviewers extracted data and assessed methodological quality following PRISMA guidelines. Pooled estimates (ES) and 95% confidence intervals (95%CIs) were calculated using random-effect models. Heterogeneity was examined in subgroup analyses. Publication bias was evaluated using Egger’s tests and Funnel plots.

From 9284 studies identified by the search, 46 studies (39 case–control,7 cohort) with over nine million participants were included, covering 33 analyses of 12 types of infection and five CC sites. Overall, maternal infection during pregnancy was associated with increased risk of CC (ES = 1.36;95%CI,1.17–1.59). Sexually transmitted infections (STIs) were associated with increased overall CC risk (ES = 2.86;95%CI,1.88–4.33). Viral infections were also associated with increased risk of overall CC (ES = 1.43;1.18,1.74), with cytomegalovirus and rubella virus infections showing positive associations upon stratification by pathogen-type. Genitourinary tract infections (GUTIs) were associated with increased risk of leukaemia (ES = 1.49;95%CI,1.05–2.12) and solid tumours (ES = 1.60, 95%CI;1.06–2.42) and viral infections with the risk of acute lymphoblastic leukaemia (ES = 1.58;95%CI,1.15–2.18).

Maternal STIs, GUTIs, and viral infections during pregnancy are associated with increased risk of CC, with GUTIs and viral infections specifically associated with increased risk of leukaemia. Targeted prevention strategies towards specific infections during pregnancy may protect against CC. Large-scale prospective studies with precise infection assessment and stratification by pathogen-type, and mechanistic considerations are needed to deepen knowledge in this area.

The online version contains supplementary material available at 10.1186/s12916-026-04625-1.

## Linked entities

- **Diseases:** childhood cancer (MONDO:0006517), leukemia (MONDO:0004355), sexually transmitted infections (MONDO:0021681)

## Full-text entities

- **Genes:** NOS1 (nitric oxide synthase 1) [NCBI Gene 4842] {aka IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS}
- **Diseases:** Infections (MESH:D007239), genital herpes (MESH:D006558), other (MESH:D058497), germ cell tumour (MESH:D009373), Bacterial infections (MESH:D001424), ROBINS-I (MESH:D010855), Brain tumours (MESH:D001932), neuroblastomas (MESH:D009447), GUTIs (MESH:C564424), syphilis (MESH:D013587), hepatoblastomas (MESH:D018197), Acute lymphoblastic leukaemias (MESH:D054218), mycoplasma pneumoniae (MESH:D011019), genital ulcers (MESH:D014456), UTI urinary tract infection (MESH:D014552), hepatocellular carcinomas (MESH:D006528), cancer (MESH:D009369), hepatitis B virus (MESH:D006509), Childhood (MESH:D063766), gonorrhoea (MESH:D006069), Maternal (MESH:D000079262), ROBINS-E (MESH:D003789), lymphoma (MESH:D008223), testicular cancers (MESH:D013736), CMV (MESH:D003586), neonatal (MESH:D007232), hepatic tumours (MESH:D008113), intrauterine growth restriction (MESH:D005317), MGCT (MESH:C563236), COVID-19 (MESH:D000086382), STI (MESH:D012749), MR (MESH:D008944), CNS (MESH:D016543), preterm birth (MESH:D047928), NHL non-Hodgkin lymphoma (MESH:D008228), flu-like illnesses (MESH:D007251), respiratory tract, urinary tract, and genitourinary tract infections (MESH:D012141), Viral infection (MESH:D014777), Leukaemia (MESH:D015458), hepatitis (MESH:D056486), rubella (MESH:D012409), retinoblastomas (MESH:D012175), AML (MESH:D015470), ALL (OMIM:615401), GCT (MESH:C537296), congenital anomalies (MESH:D000013), chlamydia (MESH:D002690), fever (MESH:D005334), prematurity (MESH:C536271), mycoplasma (MESH:D009175), pregnancy infections (MESH:D011254), varicella (MESH:D002644), EBV (MESH:D020031), Wilms tumours (MESH:D009396), inflammation (MESH:D007249), vulvar warts (MESH:D014845), carcinogenesis (MESH:D063646), common cold (MESH:D003139)
- **Chemicals:** alcohol (MESH:D000438)
- **Species:** SV40 [taxon 10633], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Human endogenous retrovirus (species) [taxon 11827], Escherichia coli (E. coli, species) [taxon 562], Human papillomavirus (species) [taxon 10566], Betapolyomavirus macacae (species) [taxon 1891767], Betapolyomavirus secuhominis (species) [taxon 1891763], Hepatitis B virus (no rank) [taxon 10407], Human betaherpesvirus 6 (species) [taxon 10368], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12849171/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12849171/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12849171/full.md

---
Source: https://tomesphere.com/paper/PMC12849171